Initial Clinical Experience with Implantation of a New Left Ventricular Assist Device HeartCon
New Left Ventricular Assist Device HeartCon
DOI:
https://doi.org/10.59958/hsf.7445Keywords:
HeartCon, left ventricular assist device, extracorporeal circulation, heart failureAbstract
Objective: Heart failure is a major health problem worldwide. We report the initial experience of a new left ventricular assist device (LVAD) Heartcon—a centrifugal pump of magnetic-fluid suspension rotor integrated with the pump and machine. From September 2020 to March 2023, HeartCon was implanted in a total of 78 cases throughout China, 27 were implanted in TEDA International Cardiovascular Hospital. Methods: The patient data collected from the medical record included patient demographics, surgical and cardiopulmonary bypass (CPB) data, doses of transfused red blood cells, mechanical ventilation time (h), intensive care unit (ICU) stay time (d), and cardiac function indices assessed by echocardiography, 6-minute walk tests, and N-terminal pro brain natriuretic peptide (NT proBNP) values. Results: All patients were in New York Heart Association (NYHA) grade IV before surgery and 21 had a dilated cardiomyopathy. All patients survived the surgery. One patient underwent heart transplantation 10 months after the implantation. Eight patients reported adverse event events. The duration of mechanical ventilation after operation was 37.8 ± 52.0 h. The incidence of hemorrhagic stroke was 7.4% and the incidence of mediastinal infection was 7.4%. At 90 day followup, 25 patients were in NYHA grade I and the other 2 patients were in grade II. Conclusion: We conclude that HeartCon implantation is a safe and useful LVAD for treatment of end-stage heart failure. It provides a shorter duration of mechanical ventilation time, and a lower incidence of hemorrhagic stroke and mediastinal infection.
References
Bragazzi NL, Zhong W, Shu J, Abu Much A, Lotan D, Grupper A, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. European Journal of Preventive Cardiology. 2021; 28: 1682–1690.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017; 135: e146–e603.
Metra M, Carubelli V, Ravera A, Stewart Coats AJ. Heart failure 2016: still more questions than answers. International Journal of Cardiology. 2017; 227: 766–777.
Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. European Journal of Heart Failure. 2017; 19: 595–602.
Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, et al. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. Journal of the American College of Cardiology. 2015; 66: 1747–1761.
Hanley C, Callum J, Karkouti K, Bartoszko J. Albumin in adult cardiac surgery: a narrative review. Canadian Journal of Anaesthesia. 2021; 68: 1197–1213.
Huang S, Zhou Z, Luo L, Yue Y, Liu Q, Feng K, et al. Preoperative serum albumin: a promising indicator of early mortality after surgery for infective endocarditis. Annals of Translational Medicine. 2021; 9: 1445.
Fritz HG, Brandes H, Bredle DL, Bitterlich A, Vollandt R, Specht M, et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiologica Scandinavica. 2003; 47: 1276–1283.
Lim SM, Kim AR, Hyun J, Lee SE, Kang PJ, Jung SH, et al. Clinical implications of pleural effusion following left ventricular assist device implantation. Acute and Critical Care. 2024; 39: 169–178.
McClure GR, Belley-Cote EP, Harlock J, Lamy A, Stacey M, Devereaux PJ, et al. Steroids in cardiac surgery trial: a substudy of surgical site infections. Canadian Journal of Anaesthesia. 2019; 66: 182–192.
Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015; 386: 1243–1253.
Sahutoglu C, Turksal E, Bilic U, Kocabas S, Zekiye Askar F, Ozturk P, et al. Anesthetic Management for Left Ventricular Assist Device Implantation Through Left Thoracotomy: Evaluation of On-Pump Versus Off-Pump. Transplantation Proceedings. 2017; 49: 587–592.
Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, et al. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. European Journal of Heart Failure. 2017; 19: 926–946.
Houston BA, Kalathiya RJ, Hsu S, Loungani R, Davis ME, Coffin ST, et al. Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. The Journal of Heart and Lung Transplantation. 2016; 35: 868–876.
Dunlay SM, Deo SV, Park SJ. Impact of tricuspid valve surgery at the time of left ventricular assist device insertion on postoperative outcomes. ASAIO Journal. 2015; 61: 15–20.
Shore S, Hanff TC, Mazurek JA, Seigerman M, Zhang R, Grandin EW, et al. The effect of transfusion of blood products on ventricular assist device support outcomes. ESC Heart Failure. 2020; 7: 3573–3581.
Meng ML, Spellman J. Anesthetic management of the patient with a ventricular assist device. Best Practice & Research. Clinical Anaesthesiology. 2017; 31: 215–226.
Tezcan B, Bölükbaşı D, Şaylan A, Turan S, Yakın SS, Kazancı D, et al. Effect of dilutional anemia that can be treated with only one unit of red blood cell transfusion on tissue oxygenation in cardiac surgery patients. Turkish Journal of Medical Sciences. 2019; 49: 1102–1108.
Bartoli CR, Hennessy-Strahs S, Gohean J, Villeda M, Larson E, Longoria R, et al. A Novel Toroidal-Flow Left Ventricular Assist Device Minimizes Blood Trauma: Implications of Improved Ventricular Assist Device Hemocompatibility. The Annals of Thoracic Surgery. 2019; 107: 1761–1767.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Seventh INTERMACS annual report: 15,000 patients and counting. The Journal of Heart and Lung Transplantation. 2015; 34: 1495–1504.
Hannan MM, Xie R, Cowger J, Schueler S, de By T, Dipchand AI, et al. Epidemiology of infection in mechanical circulatory support: A global analysis from the ISHLT Mechanically Assisted Circulatory Support Registry. The Journal of Heart and Lung Transplantation. 2019; 38: 364–373.
